Bank of New York Mellon’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345M | Sell |
|
|||||
|
2025
Q1 | $443M | Buy |
|
|||||
|
2024
Q4 | $491M | Sell |
|
|||||
|
2024
Q3 | $752M | Sell |
|
|||||
|
2024
Q2 | $908M | Sell |
|
|||||
|
2024
Q1 | $853M | Sell |
|
|||||
|
2023
Q4 | $833M | Sell |
|
|||||
|
2023
Q3 | $796M | Buy |
|
|||||
|
2023
Q2 | $693M | Sell |
|
|||||
|
2023
Q1 | $817M | Buy |
|
|||||
|
2022
Q4 | $710M | Sell |
|
|||||
|
2022
Q3 | $705M | Buy |
|
|||||
|
2022
Q2 | $566M | Buy |
|
|||||
|
2022
Q1 | $640M | Buy |
|
|||||
|
2021
Q4 | $558M | Buy |
|
|||||
|
2021
Q3 | $533M | Buy |
|
|||||
|
2021
Q2 | $480M | Buy |
|
|||||
|
2021
Q1 | $400M | Buy |
|
|||||
|
2020
Q4 | $400M | Buy |
|
|||||
|
2020
Q3 | $459M | Buy |
|
|||||
|
2020
Q2 | $482M | Buy |
|
|||||
|
2020
Q1 | $299M | Buy |
|
|||||
|
2019
Q4 | $226M | Sell |
|
|||||
|
2019
Q3 | $167M | Sell |
|
|||||
|
2019
Q2 | $189M | Sell |
|
|||||
|
2019
Q1 | $249M | Buy |
|
|||||
|
2018
Q4 | $221M | Sell |
|
|||||
|
2018
Q3 | $244M | Buy |
|
|||||
|
2018
Q2 | $206M | Buy |
|
|||||
|
2018
Q1 | $205M | Sell |
|
|||||
|
2017
Q4 | $232M | Sell |
|
|||||
|
2017
Q3 | $288M | Sell |
|
|||||
|
2017
Q2 | $378M | Sell |
|
|||||
|
2017
Q1 | $342M | Buy |
|
|||||
|
2016
Q4 | $237M | Buy |
|
|||||
|
2016
Q3 | $259M | Sell |
|
|||||
|
2016
Q2 | $228M | Sell |
|
|||||
|
2016
Q1 | $242M | Sell |
|
|||||
|
2015
Q4 | $441M | Sell |
|
|||||
|
2015
Q3 | $421M | Sell |
|
|||||
|
2015
Q2 | $477M | Sell |
|
|||||
|
2015
Q1 | $423M | Sell |
|
|||||
|
2014
Q4 | $388M | Buy |
|
|||||
|
2014
Q3 | $340M | Sell |
|
|||||
|
2014
Q2 | $279M | Sell |
|
|||||
|
2014
Q1 | $304M | Sell |
|
|||||
|
2013
Q4 | $331M | Sell |
|
|||||
|
2013
Q3 | $388M | Buy |
|
|||||
|
2013
Q2 | $243M | Buy |
|